Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome

Author:

Goodoory Vivek C.12ORCID,Ng Cho E.3,Black Christopher J.12ORCID,Ford Alexander C.12ORCID

Affiliation:

1. Leeds Institute of Medical Research at St. James's, University of Leeds Leeds UK

2. Leeds Gastroenterology Institute, St. James's University Hospital Leeds UK

3. County Durham and Darlington NHS Foundation Trust Durham UK

Abstract

SummaryBackgroundLittle is known about faecal incontinence (FI) in individuals with irritable bowel syndrome (IBS).AimsTo compare characteristics of people with IBS reporting FI, compared with people with IBS who do not report FI.MethodsWe collected demographic, gastrointestinal and psychological symptoms, healthcare usage, direct healthcare costs, impact on work and activities of daily living, and quality of life data from individuals with Rome IV‐defined IBS. We asked participants about FI, assigning presence or absence according to Rome‐IV criteria.ResultsOf 752 participants with Rome IV IBS, 202 (26.9%) met Rome IV criteria for FI. Individuals with FI were older (p < 0.001), more likely to have IBS‐D (47.0% vs. 39.0%, p = 0.008), and less likely to have attained a university or postgraduate level of education (31.2% vs. 45.6%, p < 0.001), or to have an annual income of ≥£30,000 (18.2% vs. 32.9%, p < 0.001). They were more likely to report urgency (44.6% vs. 19.1%, p < 0.001) as their most troublesome symptom and a greater proportion had severe IBS symptom scores, abnormal depression scores, higher somatic symptom‐reporting scores or higher gastrointestinal symptom‐specific anxiety scores (p < 0.01 for trend for all analyses). Mean health‐related quality of life scores were significantly lower among those with, compared with those without, FI (p < 0.001). Finally, FI was associated with higher IBS‐related direct healthcare costs (p = 0.002).ConclusionsAmong individuals with Rome IV IBS, one‐in‐four repo rted FI according to Rome IV criteria. Physicians should ask patients with IBS about FI routinely.

Funder

Tillotts Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3